diabetes
Conditions
Interventions
Non diabetic observation group:none
Sponsors
Xinyi Health Technology Co., Ltd
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. The fasting blood glucose was between 6.1-8.0mmol/l; 2. Patients aged 35-65 years old are not limited to men and women; 3. Patients with stable disease stage have no complications such as diabetic nephropathy, diabetic heart disease and diabetic neuropathy; 4. Patients who have no language and intelligence disorders and can answer and fill in the questionnaire smoothly; 5. Patients or their guardians have informed consent and are willing to participate.
Exclusion criteria
Exclusion criteria: 1. Patients with contraindications for the use of intelligent non-invasive detector: Patients with cardiac pacemaker and other implanted medical devices; patients with acute disease, infectious disease, malignant tumor, cardiovascular disease, cerebrovascular disease, liver and kidney dysfunction or other malignant diseases; skin of the collection position has scars, abrasions, new scars, scratches or inflammation; 2. Patients with fasting blood glucose > 8.0mmol/l; 3. Pregnant and lactating women; 4. Patients participating in other clinical trials; 5. Patients with acute complications of diabetes; 6. Patients with psychosis and those who cannot cooperate. Those meeting one or more of the above requirements will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Meridian energy detection;Face and tongue detection;pulse;blood sugar;ogtt;ECG, respiration;Weight, body mass index and waistline;TCM symptom integral scale;Metabonomics of blood and urine; | — |
Secondary
| Measure | Time frame |
|---|---|
| routine urine test;Blood lipid, liver function and kidney function;FFQ, IPAQ; | — |
Countries
china
Contacts
Public ContactWu Xinli
Xinyi Health Technology Co., Ltd
Outcome results
None listed